Capricor Therapeutics
CAPR
#4850
Rank
HK$14.47 B
Marketcap
HK$251.67
Share price
6.61%
Change (1 day)
232.20%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -HK$0.64 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are HK$11.13 Million. In 2024 the company made an earning of -HK$0.32 Billion a decrease over its 2023 earnings that were of -HK$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.64 Billion101.66%
2024 -HK$0.32 Billion81.57%
2023 -HK$0.18 Billion-23.2%
2022 -HK$0.23 Billion44.93%
2021 -HK$0.16 Billion46.61%
2020 -HK$0.11 Billion78.71%
2019 -HK$59.9 Million-49.7%
2018 -HK$0.12 Billion-724.78%
2017 HK$19.05 M-112.93%
2016 -HK$0.15 Billion46.27%
2015 -HK$0.11 Billion106.82%
2014 -HK$48.73 Million-48.41%
2013 -HK$94.45 Million977.23%
2012 -HK$8.77 Million-77.11%
2011 -HK$38.31 Million-22.35%
2010 -HK$49.33 Million-20.17%
2009 -HK$61.79 Million-41.17%
2008 -HK$0.11 Billion41.05%
2007 -HK$74.47 Million1098.87%
2006 -HK$6.22 Million4101.55%
2005 -HK$0.15 Million-0.97%
2004 -HK$0.15 Million17.87%
2003 -HK$0.13 Million3.66%
2002 -HK$0.13 Million-30.11%
2001 -HK$0.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.96 B-41,022.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$4.98 B-876.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$6.16 Billion 857.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.26 Billion 250.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$37.59 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$74.38 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA